Rosuvastatin is a statin-class medication primarily used to manage hypercholesterolemia and mixed dyslipidemia by inhibiting HMG-CoA reductase, an enzyme essential for cholesterol biosynthesis. By reducing… Read more


















































Rosuvastatin is a statin-class medication primarily used to manage hypercholesterolemia and mixed dyslipidemia by inhibiting HMG-CoA reductase, an enzyme essential for cholesterol biosynthesis. By reducing low-density lipoprotein (LDL) cholesterol and triglycerides, this drug helps lower the risk of cardiovascular events, including heart attacks and strokes. Pharmaceutical laboratories utilize this category of Rosuvastatin reference standards, including pharmacopeial and non-pharmacopeial impurities, to support rigorous impurity profiling and method validation. These compounds are essential for identifying degradation products and process-related substances that may arise during synthesis or storage. Furthermore, stable isotope labelled compounds are used as internal standards in mass spectrometry-based analytical methods to ensure accurate quantification of the drug and its metabolites. These high-quality reference materials are integral to maintaining regulatory compliance, facilitating stability testing, and ensuring the safety and therapeutic efficacy of the final pharmaceutical product.